EDAP TMS (EDAP)
(Delayed Data from NSDQ)
$2.68 USD
-0.01 (-0.37%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $2.65 -0.03 (-1.12%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.68 USD
-0.01 (-0.37%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $2.65 -0.03 (-1.12%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Zacks News
EDAP's Avenda Deal for AI-Assisted Cancer Care Likely to Drive Stock
by Zacks Equity Research
When combined with EDAP's Focal One platform, Avenda's Unfold AI enables more accurate and patient-specific treatment options.
Rockwell Medical Stock Surges 108.5% YTD: Should You Snap it Up Now?
by Urmimala Biswas
RMTI continues to outperform its peers, banking on its focus on optimizing business to drive sustainable profitability and meaningful cash flow generation.
Veracyte (VCYT) Stock Jumps 13.2%: Will It Continue to Soar?
by Zacks Equity Research
Veracyte (VCYT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
New Strong Sell Stocks for October 17th
by Zacks Equity Research
BAYYR, EDAP and FWRD have been added to the Zacks Rank #5 (Strong Sell) List on October 17, 2023.
SentinelOne (S) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Sentinel One's (S) fourth-quarter fiscal 2023 results are likely to reflect the benefits of strategic integrations and expanding clientele.
Cooper Companies (COO) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Cooper Companies' (COO) fiscal first-quarter results are likely to reflect segmental strength.
What's in Store for Patterson Companies (PDCO) in Q3 Earnings?
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal third-quarter results are likely to reflect an improvement at the Animal Health segment.
EDAP TMS S.A. (EDAP) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
EDAP TMS S.A. (EDAP) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Zacks.com featured highlights include Immunocore Holdings, Old Second Bancorp, EDAP TMS, Barrett Business Services and MainStreet Bancshares
by Zacks Equity Research
Immunocore Holdings, Old Second Bancorp, EDAP TMS, Barrett Business Services and MainStreet Bancshares are part of the Zacks Screen of the Week article.
Best Momentum Stocks to Buy for November 21st
by Zacks Equity Research
ACR, EDAP and H made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 21, 2022.
New Strong Buy Stocks for November 21st
by Zacks Equity Research
AMRK, ACR, EDAP, H and ENTX have been added to the Zacks Rank #1 (Strong Buy) List on November 21, 2022.
5 Stocks With Recent Price Strength to Maximize Your Gains
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are IMCR, EDAP, BBSI, OSBC and MNSB.
Is EDAP TMS (EDAP) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how EDAP TMS S.A. (EDAP) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year.
Why Earnings Season Could Be Great for EDAP TMS (EDAP)
by Zacks Equity Research
EDAP TMS (EDAP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here's Why Momentum in EDAP TMS S.A. (EDAP) Should Keep going
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, EDAP TMS S.A. (EDAP) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
What's in Store for DENTSPLY SIRONA (XRAY) in Q3 Earnings?
by Zacks Equity Research
DENTSPLY SIRONA's (XRAY) third-quarter results are likely to reflect strong performance in the Technologies & Equipment business.
PerkinElmer (PKI) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
PerkinElmer's (PKI) third-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for discovery business and informatics franchise.
Is Centene (CNC) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Centene (CNC) and EDAP TMS S.A. (EDAP) have performed compared to their sector so far this year.
Here's What Could Help EDAP TMS S.A. (EDAP) Maintain Its Recent Price Strength
by Zacks Equity Research
EDAP TMS S.A. (EDAP) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Is Bellus Health (BLU) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Bellus Health (BLU) and EDAP TMS S.A. (EDAP) have performed compared to their sector so far this year.
EDAP TMS S.A. (EDAP) Moves 7.3% Higher: Will This Strength Last?
by Zacks Equity Research
EDAP TMS S.A. (EDAP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Is EDAP TMS (EDAP) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how EDAP TMS S.A. (EDAP) and Indivior PLC (INVVY) have performed compared to their sector so far this year.
Here's Why Momentum in EDAP TMS S.A. (EDAP) Should Keep going
by Zacks Equity Research
EDAP TMS S.A. (EDAP) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Here's Why "Trend" Investors Would Love Betting on EDAP TMS S.A. (EDAP)
by Zacks Equity Research
EDAP TMS S.A. (EDAP) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Has Swedish Orphan Biovitrum (BIOVF) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Swedish Orphan Biovitrum (BIOVF) and EDAP TMS S.A. (EDAP) have performed compared to their sector so far this year.